EP1529215A1 - Vorrichtung und methoden zur durchführung von elektrischen messungen an membrankörpern - Google Patents
Vorrichtung und methoden zur durchführung von elektrischen messungen an membrankörpernInfo
- Publication number
- EP1529215A1 EP1529215A1 EP03790822A EP03790822A EP1529215A1 EP 1529215 A1 EP1529215 A1 EP 1529215A1 EP 03790822 A EP03790822 A EP 03790822A EP 03790822 A EP03790822 A EP 03790822A EP 1529215 A1 EP1529215 A1 EP 1529215A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- membrane
- electrical
- cells
- measuring arrangement
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 125
- 238000000034 method Methods 0.000 title claims description 47
- 238000005259 measurement Methods 0.000 title description 27
- 108050001175 Connexin Proteins 0.000 claims abstract description 55
- 102000010970 Connexin Human genes 0.000 claims abstract description 55
- 210000003976 gap junction Anatomy 0.000 claims abstract description 32
- 210000004027 cell Anatomy 0.000 claims description 82
- 102000004310 Ion Channels Human genes 0.000 claims description 26
- 239000000126 substance Substances 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 12
- 239000000758 substrate Substances 0.000 claims description 12
- 239000013543 active substance Substances 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 108090000862 Ion Channels Proteins 0.000 description 24
- 210000000170 cell membrane Anatomy 0.000 description 23
- 108091006146 Channels Proteins 0.000 description 19
- 102000005962 receptors Human genes 0.000 description 19
- 108020003175 receptors Proteins 0.000 description 19
- 239000000823 artificial membrane Substances 0.000 description 13
- 150000002500 ions Chemical class 0.000 description 12
- 238000013537 high throughput screening Methods 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 210000000287 oocyte Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- 241000269370 Xenopus <genus> Species 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 210000003050 axon Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000003372 electrophysiological method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 102000034287 fluorescent proteins Human genes 0.000 description 2
- 108091006047 fluorescent proteins Proteins 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000003449 plasmodesmata Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000184083 Chlosyne lacinia Species 0.000 description 1
- 241000530217 Clonostachys lucifer Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 102100037156 Gap junction beta-2 protein Human genes 0.000 description 1
- 101710198067 Gap junction beta-2 protein Proteins 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 108050003470 Innexin Proteins 0.000 description 1
- 102000014416 Innexin Human genes 0.000 description 1
- 108010036176 Melitten Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000004671 cell-free system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 210000004242 electrical synapse Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 210000003890 endocrine cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000028023 exocytosis Effects 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000003568 synaptosome Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
- G01N33/48728—Investigating individual cells, e.g. by patch clamp, voltage clamp
Definitions
- the invention relates to devices and methods for the investigation of ion channels and receptors in membranes, in particular devices and methods for carrying out simultaneous electrophysiological measurements on a collective of biological cells using connexins or innexins.
- the voltage clamp method was established as a precise and reliable method for determining the activity of ion channels and receptors in the membrane of living cells [1, 2].
- the cell to be examined is pierced with two microelectrodes, i.e. pointed glass capillaries filled with saline.
- An electrode measures the potential inside the cell, i.e. the electrical voltage dropping across the cell membrane.
- the second electrode is used to generate an electrically regulated current flow through the cell membrane.
- this current flow is regulated in such a way that the potential across the cell membrane remains constant (hence the name "voltage clamp").
- the size of the current flowing through the membrane is then a direct and very precise and timely measure of the activity of the ion channels located in the cell membrane, which are activated directly or indirectly by receptors in the cell membrane.
- the current is set to a fixed value, which is often zero, and the membrane voltage, which is now freely set, is measured (for which purpose only one microelectrode is required for a currentless measurement).
- the value of the voltage reflects the activity of those in the cell Receptors and channels, this arrangement is not as meaningful and precise as the voltage clamp method, because the relationship between the activity of the receptors and the measured voltage signal in the current clamp arrangement is usually not linear, while the measured current signal and the on - The number of open ion channels in the voltage clamp arrangement are directly proportional.
- a disadvantage of the classic electrophysiological voltage clamp and current clamp methods is that they are connected to the puncture of a microelectrode in the cell and are therefore only for very large cells, such as. B. the octopus axon,
- Muscle cells, or frog egg cells are suitable.
- the majority of all cells that would be interesting for electrophysiological experiments are much smaller and therefore inaccessible to this method.
- a second disadvantage is that this method, like all electrophysiological methods, is very complex and has to be carried out manually by experienced specialists, so that only a few experiments can be carried out per day and an industrial active ingredient search ("High Throughput Screening or HTS) is eliminated.
- a disadvantage of the patch clamp method is again the time-consuming preparation of the measurements, which only allows experienced electrophysiologists to make around 20 measurements per day. This is far less than is required for modern high-throughput processes.
- the conventional patch clamp technology requires a great deal of experience and a great deal of sensitivity and can therefore only be automated to a limited extent.
- the patch clamp pipette is replaced by a planer or a microstructured substrate.
- it can be a membrane or thin film that has been provided with small ( ⁇ m) holes [5, 6, 7].
- ⁇ m small holes
- the idea is that cells attach themselves to the holes and form a seal there similar to the Giga-Seal in the patch pipette, so that a similar electrophysiological measurement of the electrical through the hole
- Receptors or ion channels of an automatic measurement are accessible. This enabled the throughput of measurements to be increased about ten times.
- this method is only restricted to large cells, such as Xenopus oocytes, and is not suitable for small cells, which represent the vast majority of the preparations.
- the throughput of this arrangement of measurements is comparable to the automated patch clamp methods, and the throughput required for a HTS cannot be achieved in this way. Abbott, Axon, and other companies are also developing such methods.
- Bilayer can also be stabilized on the substrate with suitable chain molecules ('tethered bilayers'), [13].
- Membrane is not yet reproducible and seems to be fundamentally impossible for many types of more complex membrane receptors. However, with some simpler membrane proteins (gramizidine, alamethizine, melittin, hemolysin), [10] some potassium channels and especially connexins [14] electrical measurements on such artificial membranes could be carried out.
- Connexins Biological protein molecules, so-called connexins, which play a special role in the communication between living cells, are known to the person skilled in the art. In the meantime, about fifteen different connexins are differentiated based on their amino acid sequence [15, 16]. Connexins occur in all vertebrates and are usually abbreviated, such as B. Cx26. The number indicates the chromatographic size of the connexins in kD. Connexins with a molecular weight between 26 and 56 kD are known to date.
- a connexon is a ring-shaped structure that crosses the cell membrane and is basically able to form a very wide, non-specific ion channel or a water-filled pore. However, these pores are usually closed as long as the connexon is in the membrane of a single, healthy cell. However, if two cells touch, each of which has connexons that are compatible with each other in their membrane, then there are two
- gap junction channel also known as an electrical synapse
- a gap junctions channel is usually formed in a few minutes on contact.
- the gap junction channel formed is a structure of generally 12 identical or different connexins, or of two connexons.
- the channel has a closable central pore with a diameter of about 1.5 to 2 nm.
- the main difference to other membrane channels is that gap junction channels run through two adjacent cell membranes and therefore not a connection between the cell interior with the external medium, but create a connection between the intracellular media of the two cells.
- Gap junction channels enable inorganic ions and small water-soluble molecules up to a molecular mass of approx. 1000 Daltons to pass directly from the cytoplasm of one cell into the cytoplasm of the other
- Gap junction channels belong to the epithelial cell-to-cell connections and can be found in almost all epithelia and many other types of tissue. As a rule, many gap junction channels are organized in the form of fields, these structures then being referred to as gap junctions in the true sense.
- the gap junction channels of connected cells are usually open and the connexins stretched. If a cell experiences a massive influx of calcium from the outside, for example due to an injury, the connection to neighboring cells is interrupted by the connexins twisting allosterically.
- Connexins can be made available by purifying cell membranes from cells containing connexins, e.g. B. eye lens, heart muscle, smooth muscles, or epithelial cells and by genetic expression of the connexins in bacteria, yeast or other cells. It is also known that connexins can be provided with a marker, such as a fluorescent protein fragment, so that their presence in a cell membrane can be demonstrated using simple optical methods [17].
- a marker such as a fluorescent protein fragment
- Connexone and gap junctions often have the same properties - e.g. Pore size, ion selectivity, electrical behavior - based on how in their natural environment. It is known that between two connexons, which are embedded in artificial membranes, a functional gap junction channel is formed when the membrane surfaces come into contact [18].
- invertebrates have a functionally similar class of membrane proteins called Innexins [19].
- the channels formed with this have a larger pore, which allows molecules up to a weight of 2000 Daltons to pass through.
- Ions and small molecules pass from cell to cell. In contrast to the Channels in animal organisms, however, the plasmodesmata are limited by the plasma membrane.
- the invention relates to devices and methods for performing electrical measurements on membrane bodies, preferably biological membrane bodies. These electrical measurements allow conclusions to be drawn about the state and behavior of membrane-bound biomolecules and their reaction to any effector molecules.
- Devices according to the invention contain at least one electrical measuring apparatus (1), but preferably two electrodes (2) and a membrane (3), in which biological molecules (4) are embedded, which have the same or similar properties as innexins, connexins or connexones , Innexins, connexins or connexones are preferably embedded in the membrane.
- Innexine, Connexine or Connexone of the same type or also Innexine, Connexine or Connexone of different types can be embedded in the membrane.
- an electrolytic liquid on both sides of the membrane, which preferably has buffer properties.
- a liquid which has the properties necessary for the survival of living cells is preferably used on one side of the membrane. This includes, for example, a suitable concentration and composition of salts, a physiologically tolerable pH, possibly also the presence of nutrients and / or a suitable concentration of oxygen.
- the electrodes are preferably arranged such that there is one electrode on each side of the membrane.
- the membrane with the embedded biomolecules is preferably designed such that it has a high electrical resistance in the absence of open ion channels.
- the device according to the invention can be used for the methods according to the invention for carrying out electrical measurements on membrane bodies.
- biological membrane bodies (5) are selected, the membrane of which also contains biomolecules that have the same or similar properties as Innexine, Connexine or Connexone.
- Particularly preferred membrane bodies in the sense of the invention are living cells. These cells preferentially express connexins or innexins. Cells that normally do not express connexins or innexins can be genetically modified by transfection with cDNA, mRNA or another form of suitable sequences, or by incorporating existing connexins or innexins in another way, in such a way that the desired connexins or Innexins are built into the membrane of the cells and preferably function there exactly like Connexins and Innexins in other cells. It is preferable to choose a stable one
- membrane bodies are now preferably superimposed Gap junctions (7) on the membrane.
- the gap junctions formed in this way represent an electrical access from the side of the membrane facing away from the membrane bodies to the interior of the attached membrane bodies.
- Functional gap junctions can be detected using electrical measurements (double voltage clamp) or optical observation of the transfer of dyes with low molecular weight (e.g. Lucifer yellow). The latter allows the coupling of an ensemble of cells to be estimated using image processing methods.
- the membrane bodies according to the invention preferably contain further membrane-bound biomolecules (8) (targets), the properties of which can be investigated by the methods according to the invention.
- targets are preferably ion channels or receptors or other biomolecules which can directly or indirectly influence charge movements through membranes.
- Charge movements and / or potential differences through the membrane of the attached membrane bodies can now preferably be derived and quantified via the two electrodes.
- a particularly preferred method according to the invention is the investigation of the effects that substances have on the membrane-specific biomolecules (targets) to be examined.
- modulators i.e. inhibitors and activators of the target and other substances which influence the expression of the target
- These substances are potential active substances for the treatment of diseases which are related to the function of the respective target.
- the invention further relates to the active substances found using the methods according to the invention and to processes for their preparation.
- Electrical signals in the sense of the invention, are physical quantities which are related to the distribution of electrical charges, ie electrons, protons, or ions, in the system under consideration. Electrical signals that can be recorded in devices according to the invention are, for example, the electrical current strength, the electrical capacitance, or the electrical potential difference and
- Membrane bodies in the sense of the invention are volume elements surrounded by a membrane and filled with a liquid.
- Membrane bodies according to the invention are preferably biological membrane bodies, such as e.g. living cells. These include cells that have been isolated from living tissues by dissociation (primary cultures). This also includes cells that are kept in culture as established cell lines, such as CHO cells, HEK cells, NIH3T3 cells, HeLa cells, but also transiently transfected cells or primary cells.
- Biological membrane bodies, in the sense of the invention are also artificially produced membrane bodies, in which e.g. a lipid bilayer encloses a limited volume of an aqueous medium (vesicle).
- membrane bodies then preferably contain at least one biological component, e.g. a polypeptide embedded in the lipid bilayer, a membrane-bound enzyme, an ion channel or a G protein-coupled receptor.
- Biological membrane bodies in the sense of the invention, can also be bacterial cells, fungal cells or cells of other unicellular or multicellular organisms.
- Biological membrane bodies within the meaning of the invention are e.g. also protoplasts of fungal cells and plant cells, which are achieved by removing external cell walls or similar structures.
- Biological membrane body in
- the invention furthermore also includes membrane bodies which, such as synaptosomes, are produced by cleavage or association from the membranes of living organisms or which have been obtained by combining such preparations with synthetic lipid vesicles.
- Electrical measuring apparatus in the sense of the invention, is a device that allows electrical signals to be recorded and, if necessary, quantified.
- membrane potential is the electrical potential difference between the opposite sides of a membrane.
- Active ingredients in the sense of the invention are substances that can influence the activity of biological molecules.
- Preferred active substances in the sense of the invention are those which specifically influence the activity of individual biological molecules or of groups of biological molecules. Particularly preferred
- Active substances are those which influence the activity of receptors and / or ion channels.
- “Supported bilayer” are membranes that are on the one hand in contact with or in the immediate vicinity of a suitable solid, porous or gel-like
- the present invention relates to 1. a measuring arrangement for measuring electrical signals on membrane bodies containing an electrical measuring apparatus (1), electrodes (2), a membrane (3) containing connexins or innexins (4), and a membrane body (5) also containing connexins or Innexine (6) characterized in that an electrically conductive access from the side of the membrane facing away from the membrane body to the inside of the membrane body through gap junction
- Affect receptors and / or ion channels (8) characterized in that i) at least one membrane body (5) containing said receptors and / or ion channels is brought into contact with at least one test substance, and ii) at least one electrical signal on the membrane body or the Membrane bodies are measured with a measuring arrangement according to point 1,
- test substances which influence the measured electrical signal are selected as active substances.
- a method for transporting substances into a membrane body or out of a membrane body characterized in that the substance through gap junction channels into or out of the membrane body
- Membrane body came out.
- the substance to be transported follows an electrical potential gradient, a concentration gradient, or a pressure gradient over the membrane of the arrangement according to the invention
- FIG. 1 shows a typical measuring arrangement in the sense of the invention with electrical measuring apparatus (1), electrodes (2), a membrane (3) containing connexins or innexins (4), a membrane body (5), gap junction channels (7) and targets ( 8th).
- a measuring arrangement for measuring electrical signals on membrane bodies is shown in Figure 1. It consists of an electrode (e.g. a gold electrode) at the bottom of a small chamber, e.g. a chamber in a microtiter plate.
- An electrically dense artificial membrane (3) is attached above the electrode, an electrolyte solution as an ion reservoir being located in the space between the membrane and the electrode.
- the measuring arrangement has a second electrode, which is located above the artificial membrane.
- Functional hemichannels (connexones) are introduced into the artificial membrane in such a way that they can diffuse freely in the membrane and that their normally extracellular domain is located above (trans) the membrane.
- suitable types of connexins are used. Possibly.
- connexones are built up from more than one connexin (heteromeric connexones).
- the suitable connexins are selected according to the requirements of the intended test. The procedure is such that an electrical signal which is as small as possible is measured without additions of the active substances to be investigated, and when the active substances interact with the ion channels and / or receptors (8) to be investigated, the observed signal increases as much as possible.
- a suspension with suitable cells is added to said chamber, which already contains the artificial membrane as described above.
- These cells (5) have at least one ion channel or receptor (8) to be examined in the cell membrane and additionally hemichannels (6), which form functional gap junctions (7) in a suitable manner with the hemichannels in the artificial membrane (4) of the measuring arrangement ,
- the hemichannels in the artificial membrane are initially closed as long as there is no cell in place. This is ensured by the fact that an electrical voltage is applied across the membrane.
- an electrical voltage is applied across the membrane.
- gap junctions are formed between neighboring cells, or that some of the cells only establish a conductive connection to the ion reservoir indirectly via other cells.
- this is not an obstacle to the use of this arrangement according to the invention. Rather, this can even result in an amplification of the observed signal, which further improves the sensitivity of the measuring arrangement.
- Connexons with a voltage behavior such that they are closed as a hemichannel or as a hemichannel are only particularly suitable for the measuring arrangement with a low potential difference (for example less than 20 mV) across the cell membrane and closed with a larger potential difference.
- the result of the measurement is therefore a current signal which corresponds to the total current flow through the cell membranes of all those cells which are in conductive connection with the ion reservoir via the built-in gap junctions.
- Suitable measuring arrangement the electrical behavior of ion channels and receptor to determine directly and immediately, with high precision and good temporal resolution and also to precisely demonstrate and evaluate the changes in this behavior, which are triggered, for example, by known or potential active ingredients.
- the time resolution of the measurement arrangement is determined by the electrical properties of the gap junctions, which in their natural function have a time resolution in the sub-millisecond range.
- the formation of the desired lead configuration in which the cells adjacent to the substrate establish an electrical connection with the ion reservoir by means of gap junctions, can also be monitored with electrical measurements.
- the electronic capacitance of the membrane and the membrane bodies connected to it via gap junctions can be determined using suitable electronic measurement methods known to the person skilled in the art.
- This method is suitable to determine the total membrane area of the system and thus to determine the number of attached cells connected to the membrane via gap junctions.
- This signal can also be used to determine the influence of test substances on this arrangement. In particular, the occurrence of exocytosis in the attached membrane bodies can be determined in this way.
- Molecular weight such as B. Lucifer Yellow, which can diffuse through gap junction channels.
- the measured signal can be normalized so that the results different experiments can be compared directly with similar but different experimental arrangements.
- Example 1 The structure described in Example 1 is modified in such a way that several or a larger number of the chambers described are set up next to one another, so that, for example, each chamber of a microtiter plate represents a measuring arrangement according to Example 1.
- the individual measuring chambers are read out sequentially, in groups or simultaneously.
- Multi-channel amplifier systems such as those known from MEA (multi-electrode array) technology or detectors in high-energy physics can be used for this.
- the microtiter plate For example, those with 96, 384, 1536 or any other number of chambers are used as the microtiter plate.
- the measuring arrangement is thus preferably designed such that it is mechanically and geometrically compatible with the HTS systems and systems already established in drug discovery, so that there are no obstacles to the technical application of the invention for practical drug searches. Existing pipetting and dispensing devices can then continue to be used. Only the detection system is expanded by a suitable readout head, which is able to read the electrical signals from the microtiter plates.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10236528 | 2002-08-09 | ||
| DE10236528A DE10236528A1 (de) | 2002-08-09 | 2002-08-09 | Vorrichtung und Methoden zur Durchführung von elektrischen Messungen an Membrankörpern |
| PCT/EP2003/008299 WO2004021002A1 (de) | 2002-08-09 | 2003-07-28 | Vorrichtung und methoden zur durchführung von elektrischen messungen an membrankörpern |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1529215A1 true EP1529215A1 (de) | 2005-05-11 |
Family
ID=30469635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP03790822A Withdrawn EP1529215A1 (de) | 2002-08-09 | 2003-07-28 | Vorrichtung und methoden zur durchführung von elektrischen messungen an membrankörpern |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050227139A1 (https=) |
| EP (1) | EP1529215A1 (https=) |
| JP (1) | JP4498139B2 (https=) |
| AU (1) | AU2003253343B2 (https=) |
| CA (1) | CA2494927A1 (https=) |
| DE (1) | DE10236528A1 (https=) |
| WO (1) | WO2004021002A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7244349B2 (en) | 1997-12-17 | 2007-07-17 | Molecular Devices Corporation | Multiaperture sample positioning and analysis system |
| US20020144905A1 (en) | 1997-12-17 | 2002-10-10 | Christian Schmidt | Sample positioning and analysis system |
| US7266457B1 (en) * | 1999-05-21 | 2007-09-04 | Hesperos, Llc | High throughput functional genomics |
| US7270730B2 (en) | 2000-08-04 | 2007-09-18 | Essen Instruments, Inc. | High-throughput electrophysiological measurement system |
| US7067046B2 (en) | 2000-08-04 | 2006-06-27 | Essen Instruments, Inc. | System for rapid chemical activation in high-throughput electrophysiological measurements |
| EP1588616A3 (en) * | 2004-04-19 | 2011-09-07 | Becton Dickinson and Company | Method of transporting transgenic Xenopus laevis oocytes |
| JP4897681B2 (ja) * | 2004-07-23 | 2012-03-14 | エレクトロニック・バイオサイエンシーズ・エルエルシー | イオン・チャネルを通過する時間的に変化する電流を検出するための方法及び装置 |
| JP2007225300A (ja) * | 2006-02-21 | 2007-09-06 | Mie Univ | 物質認識機能と情報変換機能を併せ持つセンサー |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5874668A (en) * | 1995-10-24 | 1999-02-23 | Arch Development Corporation | Atomic force microscope for biological specimens |
| GB9812783D0 (en) * | 1998-06-12 | 1998-08-12 | Cenes Ltd | High throuoghput screen |
| JP2002522028A (ja) * | 1998-07-23 | 2002-07-23 | シンビオシス ゲーエムベーハー | 細胞外電気生理学的記録用アッセンブリと装置及びその使用 |
| DE10102117A1 (de) * | 2001-01-18 | 2002-08-08 | Diehl Ako Stiftung Gmbh & Co | Verfahren zum schnellen Starten eines Asynchronmotors |
| GB0119438D0 (en) * | 2001-02-16 | 2001-10-03 | Aventis Pharm Prod Inc | Gap junction permeability assay |
| WO2003032964A2 (en) * | 2001-10-17 | 2003-04-24 | University Of Wales College Of Medecine | Gap junctions and endothelial-derived hyperpolarizing factor (edhf) |
| HRP20040784A2 (en) * | 2002-01-29 | 2005-04-30 | Wyeth | Compositions and methods for modulating connexin hemichannels |
-
2002
- 2002-08-09 DE DE10236528A patent/DE10236528A1/de not_active Withdrawn
-
2003
- 2003-07-28 JP JP2004531823A patent/JP4498139B2/ja not_active Expired - Fee Related
- 2003-07-28 CA CA002494927A patent/CA2494927A1/en not_active Abandoned
- 2003-07-28 EP EP03790822A patent/EP1529215A1/de not_active Withdrawn
- 2003-07-28 WO PCT/EP2003/008299 patent/WO2004021002A1/de not_active Ceased
- 2003-07-28 US US10/523,784 patent/US20050227139A1/en not_active Abandoned
- 2003-07-28 AU AU2003253343A patent/AU2003253343B2/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2004021002A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| DE10236528A1 (de) | 2004-02-19 |
| AU2003253343A1 (en) | 2004-03-19 |
| CA2494927A1 (en) | 2004-03-11 |
| JP2005535906A (ja) | 2005-11-24 |
| WO2004021002A1 (de) | 2004-03-11 |
| AU2003253343B2 (en) | 2009-04-30 |
| JP4498139B2 (ja) | 2010-07-07 |
| US20050227139A1 (en) | 2005-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1040349B2 (de) | Positionierung und elektrophysiologische charakterisierung einzelner zellen und rekonstituierter membransysteme auf mikrostrukturierten trägern | |
| EP1368488B1 (de) | Sensoranordnung, vorrichtung und verfahren zur amperometrischen und/oder potentiometrischen, pharmakologischen wirkort- und/oder wirkstofftestung | |
| DE602004013042T2 (de) | Testchip sowie verwendungen des testchips zur bestimmung molekularer strukturen und funktionen | |
| EP2483673B1 (de) | Anordnung und verfahren unter verwendung von mikrosensoren zum messen von zell-vitalitäten | |
| DE202005022036U1 (de) | Paralleles Patch-Clamp-System | |
| EP1529215A1 (de) | Vorrichtung und methoden zur durchführung von elektrischen messungen an membrankörpern | |
| WO2003020125A2 (de) | Vorrichtung und verfahren zur erfassung bioelektrischer signale aus elektrophysiologisch aktiven bereichen in sphäroiden | |
| EP1660886B1 (de) | Vorrichtungen zum nachweis biochemischer aktivität enthaltend gap junctions | |
| EP1623224A2 (de) | Biokompatible sensorelektrodenanordnung und verfahren zu deren herstellung | |
| DE10243599A1 (de) | Messvorrichtung und -verfahren für ein Screening bei auf Elektroden immobilisierten Zellen | |
| EP2607475B1 (de) | Monitoringzelle und Verfahren zur Analyse eines Zell- und Gewebewachstums | |
| EP1807696B1 (de) | Vorrichtung und verfahren zur messung von zelleigenschaften | |
| DE10244129B4 (de) | H+-K+-ATPase-Assay | |
| DE60110598T2 (de) | Quantitatives fluoreszenz-bestimmungsverfahren für transportproteinenaktivität | |
| DE20104431U1 (de) | Sensorelektrodeneinrichtung, Sensoranordnung und Vorrichtung zur amperometrischen und/oder potentiometrischen, insbesondere pharmakologischen Wirkort- und/oder Wirkstofftestung | |
| EP2092319A1 (de) | Vorrichtung und verfahren zur messung biologischer und elektronischer eigenschaften einer probe | |
| DE102006011925B3 (de) | Typ-PAT1-Protein-Assay | |
| DE102007006585B3 (de) | Verfahren zum Identifizieren eines Wirkstoffkomplexes, welcher eine enzymatische Eigenschaft eines synaptosomalen/synaptischen Wirkortkomplexes im Bereich einer synaptosomalen/synaptischen Membran modifiziert | |
| Bäumler | A novel measurement setup for impedance-based analysis of 3D tissue models: design, characterization and application | |
| DE10202482B4 (de) | Molekularer Sensorkomplex, Messsondenanordnung und Verfahren zur pharmakologischen Wirkstoff- und/oder Wirkorttestung | |
| DE102011080772B3 (de) | Vorrichtung, System und Verfahren zum Detektieren einer Sinneswahrnehmung | |
| EP2336767A1 (de) | Mittel zum Nachweis biochemischer Aktivität von Membrankörpern | |
| DE102006032953A1 (de) | Biosensorrohling und Verfahren zum Herstellen einer Biosensoranordnung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20050309 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20100427 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20110719 |